Literature DB >> 26070453

The Role of Central Nervous System Mechanisms in Resistant Hypertension.

Dagmara Hering1, Markus Schlaich.   

Abstract

Arterial hypertension remains a primary global health problem with significant impact on cardiovascular morbidity and mortality. The low rate of hypertension control and failure to achieve target blood pressure levels particularly among high-risk patients with resistant hypertension has triggered renewed interest in unravelling the underlying mechanisms to implement therapeutic approaches for better patient management. Here, we summarize the crucial role of neurogenic mechanisms in drug-resistant hypertension, with a specific focus on central control of blood pressure, the factors involved in central integration of afferent signalling to increase sympathetic drive in resistant hypertension, and briefly review recently introduced interventional strategies distinctively targeting sympathetic activation.

Entities:  

Mesh:

Year:  2015        PMID: 26070453     DOI: 10.1007/s11906-015-0570-0

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  63 in total

Review 1.  Functional role of renal afferents.

Authors:  A Stella; A Zanchetti
Journal:  Physiol Rev       Date:  1991-07       Impact factor: 37.312

2.  Sustained reduction of hypertension by deep brain stimulation.

Authors:  Erlick A C Pereira; Shouyan Wang; David J Paterson; John F Stein; Tipu Z Aziz; Alexander L Green
Journal:  J Clin Neurosci       Date:  2009-08-06       Impact factor: 1.961

3.  Health-related quality of life after renal denervation in patients with treatment-resistant hypertension.

Authors:  Gavin W Lambert; Dagmara Hering; Murray D Esler; Petra Marusic; Elisabeth A Lambert; Stephanie K Tanamas; Jonathan Shaw; Henry Krum; John B Dixon; David A Barton; Markus P Schlaich
Journal:  Hypertension       Date:  2012-10-15       Impact factor: 10.190

Review 4.  Nucleus locus ceruleus: new evidence of anatomical and physiological specificity.

Authors:  S L Foote; F E Bloom; G Aston-Jones
Journal:  Physiol Rev       Date:  1983-07       Impact factor: 37.312

Review 5.  Central nervous system monoamine neurotransmitter turnover in primary and obesity-related human hypertension.

Authors:  M Esler; G Lambert; M Vaz; J Thompson; D Kaye; V Kalff; M Kelly; A Turner; G Jennings
Journal:  Clin Exp Hypertens       Date:  1997 Jul-Aug       Impact factor: 1.749

6.  Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

Authors:  Henry Krum; Markus P Schlaich; Paul A Sobotka; Michael Böhm; Felix Mahfoud; Krishna Rocha-Singh; Richard Katholi; Murray D Esler
Journal:  Lancet       Date:  2013-11-07       Impact factor: 79.321

7.  Relationship of neurovascular compression to central sympathetic discharge and essential hypertension.

Authors:  Paul A Smith; James F M Meaney; Lee N Graham; John B Stoker; Alan F Mackintosh; David A S G Mary; Stephen G Ball
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

8.  Baroreflex sensitivity and heredity in essential hypertension.

Authors:  R J Parmer; J H Cervenka; R A Stone
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

9.  Neurovascular pulsatile compression and neurosurgical decompression of the rostral ventrolateral medulla in medically resistant hypertensive patients.

Authors:  Peter Legrady; Erika Voros; Dora Bajcsi; Sandor Sonkodi; Pal Barzo; Gyorgy Abraham
Journal:  Kidney Blood Press Res       Date:  2009-01-22       Impact factor: 2.687

10.  Observations of changes of blood pressure before and after neurosurgical decompression in hypertensive patients with different types of neurovascular compression of brain stem.

Authors:  Peter Legrady; Erika Voros; Dora Bajcsi; Imola Fejes; Pal Barzo; Gyorgy Abraham
Journal:  Kidney Blood Press Res       Date:  2013-10-18       Impact factor: 2.687

View more
  10 in total

Review 1.  Centrally Mediated Cardiovascular Actions of the Angiotensin II Type 2 Receptor.

Authors:  U Muscha Steckelings; Annette de Kloet; Colin Sumners
Journal:  Trends Endocrinol Metab       Date:  2017-07-18       Impact factor: 12.015

Review 2.  Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.

Authors:  Raven Voora; Alan L Hinderliter
Journal:  Curr Hypertens Rep       Date:  2018-09-07       Impact factor: 5.369

3.  Renal denervation for resistant hypertension: yes.

Authors:  Enrico Boschetti; Yahya Alrashdi; Giuseppe Schillaci
Journal:  Intern Emerg Med       Date:  2016-03-12       Impact factor: 3.397

Review 4.  Neurogenic hypertension: pathophysiology, diagnosis and management.

Authors:  Samuel J Mann
Journal:  Clin Auton Res       Date:  2018-07-04       Impact factor: 4.435

5.  Overexpression of the neuronal human (pro)renin receptor mediates angiotensin II-independent blood pressure regulation in the central nervous system.

Authors:  Hua Peng; Dane D Jensen; Wencheng Li; Michelle N Sullivan; Sophie A Buller; Caleb J Worker; Silvana G Cooper; Shiqi Zheng; Scott Earley; Curt D Sigmund; Yumei Feng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-12-15       Impact factor: 4.733

6.  Increased (pro)renin receptor expression in the subfornical organ of hypertensive humans.

Authors:  Silvana G Cooper; Darshan P Trivedi; Rieko Yamamoto; Caleb J Worker; Cheng-Yuan Feng; Jacob T Sorensen; Wei Yang; Zhenggang Xiong; Yumei Feng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-12-22       Impact factor: 4.733

Review 7.  Renal denervation based on experimental rationale.

Authors:  Kenichi Katsurada; Yukako Ogoyama; Yasushi Imai; Kaushik P Patel; Kazuomi Kario
Journal:  Hypertens Res       Date:  2021-09-13       Impact factor: 5.528

Review 8.  Sympathetic Activation in Chronic Heart Failure: Potential Benefits of Interventional Therapies.

Authors:  Kamila Lachowska; Marcin Gruchała; Krzysztof Narkiewicz; Dagmara Hering
Journal:  Curr Hypertens Rep       Date:  2016-07       Impact factor: 5.369

9.  Endothelium-independent vasorelaxant effect of 20(S)-protopanaxadiol on isolated rat thoracic aorta.

Authors:  Lu Gan; Zhen-Hua Wang; Hong Zhang; Xin Zhou; Hui Zhou; Chao Sun; Jing Si; Rong Zhou; Cheng-Jun Ma; Ji Li
Journal:  Acta Pharmacol Sin       Date:  2016-09-12       Impact factor: 6.150

Review 10.  Mechanisms in hypertension and target organ damage: Is the role of the thymus key? (Review).

Authors:  Xianliang Dai; Li Hua; Yihong Chen; Jiamei Wang; Jingyi Li; Feng Wu; Yanda Zhang; Jiyuan Su; Zonggui Wu; Chun Liang
Journal:  Int J Mol Med       Date:  2018-03-30       Impact factor: 4.101

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.